Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain tumors in children.

Andrew W Walter1, Joanne M Hilden

  • 1Pediatric Hematology/Oncology and Neuro-Oncology, Thomas Jefferson Medical College, A. I. duPont Hospital for Children, 1600 Rockland Road, Wilmington, DE 19899, USA. awwalter@nemours.org

Current Oncology Reports
|October 16, 2004
PubMed
Summary

Pediatric brain tumors present complex diagnostic and treatment challenges. Aggressive therapies are vital but can cause significant long-term effects on the developing brain, necessitating ongoing research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variants.

Journal of neuro-oncology·2026
Same author

PTPN11-Related Noonan Syndrome Predisposes to Multifocal Low-Grade CNS Tumors Harboring FGFR1 Variants.

Research square·2026
Same author

Mechanical properties of pediatric low-grade gliomas in children with and without neurofibromatosis type 1.

Neuroradiology·2024
Same author

Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children's Oncology Group study.

Leukemia·2024
Same author

WNT-activated, MYC-amplified medulloblastoma displaying intratumoural heterogeneity.

Neuropathology and applied neurobiology·2023
Same author

<i>KMT2A</i> partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study.

Haematologica·2023

Area of Science:

  • Pediatric neuro-oncology
  • Developmental neuroscience
  • Clinical oncology

Background:

  • Pediatric brain tumors are a diverse and challenging group of diseases.
  • Accurate diagnosis and treatment remain areas of significant controversy.
  • Aggressive therapies are often required for lethal pediatric brain tumors.

Purpose of the Study:

  • To highlight the challenges in pediatric neuro-oncology.
  • To underscore the need for continued research in diagnosis and treatment.
  • To address the complexities of late effects from aggressive therapies.

Main Methods:

  • Review of current diagnostic and treatment controversies.
  • Analysis of the impact of aggressive therapies on brain development.
  • Identification of key areas for future clinical and basic research.

Main Results:

  • Pediatric brain tumors exhibit significant divergence in presentation and behavior.
  • Aggressive treatment is necessary but poses risks of late effects.
  • The developing brain is particularly vulnerable to treatment-related injury.

Conclusions:

  • Pediatric neuro-oncology is a critical research area due to treatment complexities.
  • Balancing aggressive treatment with minimizing long-term neurological deficits is paramount.
  • Further research is essential for improving outcomes in pediatric brain tumor patients.

Related Experiment Videos